120 -5 (55) 2023 — Nasirova Sabina Zaurovna — THE MAIN COMPOSITION AND EFFECT OF MILK THISTLE ON THE BODY

THE MAIN COMPOSITION AND EFFECT OF MILK THISTLE ON THE BODY

Nasirova Sabina Zaurovna Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Providing the population of Uzbekistan with effective and safe medicines is one of the priorities of pharmacy. In accordance with the Decree of the President of the Republic of Uzbekistan dated 20.05.2022 N PP-251 “On measures for the organization of cultural cultivation, processing and widespread use of medicinal plants in treatment” becomes more significant. In this regard, medicinal herbal preparations (MHP), which have a wide range of therapeutic effects and a number of advantages in comparison with drugs of synthetic origin, are of particular relevance. MHP is distinguished by a relatively low risk of developing allergies, a milder therapeutic effect and safety

Key words: Milk thistle, hepatoprotectors, medicinal plants.

First page

686

Last page

689

For citation: Nasirova Sabina Zaurovna – THE MAIN COMPOSITION AND EFFECT OF MILK THISTLE ON THE BODY //New Day in Medicien 2023 5(55): 686-689 https://newdaymedicine.com/index.php/2023/06/19/l-194/

LIST OF REFERENCES:

1. 1.ФАРМиндекс: ПРАКТИК, выпуск 3 – СПб.: ООО «ФАРМиндекс», 2002 136.
2. Berkson BM. A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. Med Klin 1999 Oct 15;94(3):84-9.
3. Deak G, Muzes G, Lang I, et al. Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases. Orv Hetil 1990 131:1291–1292;
4. Feher J, Deak G, Muzes G, et al. Liver–protective action of silymarin therapy in chronic alcoholic liver diseases. Orv Hetil 1989 130:2723–2727;.
5. Ferenci P, Dragosics B, Dittrich H, Frank H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989 9:105–113;
6. Lang I, Nekam K, Deak G, et al. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers. Ital J Gastroenterol 1990 22:283–7;
7. Magliulo E, Gagliardi B, Fiori GP. Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres. Med Klin 1978 73:1060–1065;
8. Muzes G, Deak G, Lang I, et al. Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol). Orv Hetil 1990 131:863–866;
9. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen–related disease. Semin Liver Dis 1993 13:289–301;
10. Salmi HA, Sarna S. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double–blind controlled study. Scand J Gastroenterol 1982 17:517–521;